Literature DB >> 17011635

Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples.

Keith H Nuechterlein1, David J Miklowitz, Joseph Ventura, Michael J Gitlin, Mitchell Stoddard, David Lukoff.   

Abstract

Research on predicting and preventing episodes of schizophrenia and mood disorder lacks consistent, specific definitions of episodes. We present an operational system for identifying relapse, exacerbation, and remission of schizophrenia and bipolar disorder within longitudinal studies that involve repeated symptom assessments. Three major classes of episodic outcome are defined: relapse or significant exacerbation, nonrelapse, and stable, severe persisting symptoms. These major classes are further subdivided to distinguish nine categories of episodic outcome. To examine ease of use, interrater reliability, and validity, the classification system was applied to recent-onset samples of schizophrenia patients (N=77) and bipolar mood disorder patients (N=23) followed on medication for 9- to 12-month periods. A range of episodic outcomes were distinguished with high interrater reliability. Despite being prescribed continuous medication, 21% of the recent-onset schizophrenia patients and 61% of bipolar patients met criteria for relapse or significant exacerbation during this follow-up period. Predictive relationships support the validity of this system for classifying episodes. A computer program is available to facilitate its use. Use of these explicit definitions of episodes may help to clarify the relationship between episodic outcome and other fundamental domains of illness outcome, particularly other symptom dimensions, work functioning, and social functioning.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011635     DOI: 10.1016/j.psychres.2004.04.018

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  24 in total

Review 1.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

2.  Psychophysiological prodromal signs of schizophrenic relapse: a pilot study.

Authors:  Michael E Dawson; Anne M Schell; Anthony Rissling; Joseph Ventura; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2010-08-17       Impact factor: 4.939

3.  Expressed emotion and sociocultural moderation in the course of schizophrenia.

Authors:  Adrian Aguilera; Steven R López; Nicholas J K Breitborde; Alex Kopelowicz; Roberto Zarate
Journal:  J Abnorm Psychol       Date:  2010-11

4.  Association of the Jumping to Conclusions and Evidence Integration Biases With Delusions in Psychosis: A Detailed Meta-analysis.

Authors:  Benjamin F McLean; Julie K Mattiske; Ryan P Balzan
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

5.  Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.

Authors:  George Bartzokis; Po H Lu; Erika P Raven; Chetan P Amar; Nicole R Detore; Alexander J Couvrette; Jim Mintz; Joseph Ventura; Laurie R Casaus; John S Luo; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2012-07-17       Impact factor: 4.939

6.  Applications of temporal kernel canonical correlation analysis in adherence studies.

Authors:  Majnu John; Todd Lencz; Janina Ferbinteanu; Juan A Gallego; Delbert G Robinson
Journal:  Stat Methods Med Res       Date:  2015-08-20       Impact factor: 3.021

7.  Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training.

Authors:  Keith H Nuechterlein; Kenneth L Subotnik; Joseph Ventura; Luana R Turner; Michael J Gitlin; Denise Gretchen-Doorly; Deborah R Becker; Robert E Drake; Charles J Wallace; Robert P Liberman
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

8.  Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.

Authors:  Joseph Ventura; Kenneth L Subotnik; Michael J Gitlin; Denise Gretchen-Doorly; Arielle Ered; Kathleen F Villa; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-12-08       Impact factor: 4.939

9.  Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches.

Authors:  Keith H Nuechterlein; Joseph Ventura; Kenneth L Subotnik; Jacqueline N Hayata; Alice Medalia; Morris D Bell
Journal:  Am J Psychiatr Rehabil       Date:  2014-07

10.  Multifamily psychoeducation for first-episode psychosis: a cost-effectiveness analysis.

Authors:  Nicholas J K Breitborde; Scott W Woods; Vinod H Srihari
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.